Pricing Log in Create free account

Iovance Biotherapeutics, Inc. (IOVA) vs Tango Therapeutics, Inc. (TNGX)

Iovance Biotherapeutics, Inc. and Tango Therapeutics, Inc. are both Biotechnology companies. Iovance Biotherapeutics, Inc. and Tango Therapeutics, Inc. are of similar size ($3.5B and $3.5B). Iovance Biotherapeutics, Inc. grew revenue faster over the last twelve months: 51.3% against 48.3%. Tango Therapeutics, Inc. has the higher net margin (0.00% vs −58.2%) and the lower return on invested capital (−808.4% vs −17.7%). Across the 16 metrics below, Tango Therapeutics, Inc. leads on 11 and Iovance Biotherapeutics, Inc. on 5.

Valuation

Metric IOVA TNGX Biotechnology median
P/E n/m n/m 10.26
P/S 9.29 50.96 9.18
P/B 4.33 3.10 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 8.51 34.70 8.98
Earnings yield (6.78%) (3.96%) (34.89%)
Free cash flow yield (6.14%) (4.54%) (24.52%)

Profitability

Metric IOVA TNGX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin (60.79%) 0.00% 0.00%
Net margin (58.19%) 0.00% 0.00%
Free cash flow margin (57.01%) 0.00% 0.00%
Return on equity (29.11%) (21.34%) (50.12%)
Return on assets (23.26%) (18.86%) (45.60%)
Return on invested capital (17.72%) (808.35%) 0.00%

Growth

Metric IOVA TNGX Biotechnology median
Revenue growth (TTM) 51.34% 48.29% 6.26%
EPS growth (last fiscal year) 14.84% 26.89% 29.88%
Revenue growth, 5-year CAGR — 52.13% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IOVA TNGX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.20 50.82 4.89
Net debt to EBITDA 0.82 3.08 1.01

Dividend

Metric IOVA TNGX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IOVA TNGX Biotechnology median
Market cap 3.51b 3.52b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack